RegisterLogin

SG-210

CAT: 0804-HY-106915Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-106915Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SG-210 (SPR 210) is an orally active and selective aldose reductase (AR) inhibitor. SG-210 has IC50 values of 9.5 nM and 10 nM for AR from porcine lens and human placenta, respectively. SG-210 can inhibit sorbitol accumulation and ameliorate diabetic neuropathy and retinopathy in Streptozotocin (HY-13753) -induced diabetic rats. SG-210 can be used in the research of diseases such as diabetes-related complications[1].
CAS Number
[143162-65-6]
Product Name Alternative
SPR 210
UNSPSC
12352005
Target
Aldose Reductase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Neurological Disease
Smiles
O=C1N(CC2=NC3=C(S2)C(F)=CC(F)=C3F)C4=CC=CC=C4SC1CC(O)=O
Molecular Formula
C18H11F3N2O3S2
Molecular Weight
424.42
References & Citations
[1]Matsui T, et al. Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats. Jpn J Pharmacol. 1994 Feb;64 (2) :115-24.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-129445-01SG-209
HY-114688BITC-SG
HY-1399761-SG
HY-148816-01SG-094
HY-136554-01WYC-210
HY-19350-01BML-210
HY-100003-01ML-210
HY-117614WF-210
HY-15861-01Targapremir-210
HY-161973Hydroxyl-ML-210

Alternative Products

CatalogName
abx085032-01SG-PEG-SG
HO027027-10KSG-PEG-SG, 10K
HO027027-1KSG-PEG-SG, 1K
HO027027-5KSG-PEG-SG, 5K
HO027027-2KSG-PEG-SG, 2K
HO027027-20KSG-PEG-SG, 20K
HO027027-3.4KSG-PEG-SG, 3.4K
T9901A-1732-01SG-001
T25160-01BITC-SG
T24786-01SG-209

Popular Products